CastleKnight Management’s Core Scientific CORZ Stock Holding History

CastleKnight Management’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.46M	Sell	252,360 -15,700	-6%	-$370K	0.09%	165
2026 Q1	$4.01M	Sell	268,060 -66,000	-20%	-$1.13M	0.07%	199
2025 Q4	$4.86M	Sell	334,060 -73,900	-18%	-$1.29M	0.11%	116
2025 Q3	$7.32M	Sell	407,960 -74,040	-15%	-$1.09M	0.14%	111
2025 Q2	$8.23M	Sell	482,000 -1,371,300	-74%	-$13.7M	0.23%	73
2025 Q1	$13.4M	Buy	1,853,300 +1,366,300	+281%	+$15.6M	0.53%	27
2024 Q4	$6.84M	Sell	487,000 -24,000	-5%	-$355K	0.2%	64
2024 Q3	$6.06M	Buy	511,000 +129,200	+34%	+$1.34M	0.25%	54
2024 Q2	$3.55M	Buy	+381,800	New	+$1.95M	0.18%	87

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

CastleKnight Management's CORZ Position: Q2 2026 in Review

CastleKnight Management reduced its Core Scientific (CORZ) stake by 5.9% in Q2 2026, selling an estimated $370K and leaving 252,360 shares worth $6.46M. The position accounts for 0.09% of the portfolio, ranked #165.

CastleKnight Management first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $13.4M in Q1 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

CastleKnight Management held 252,360 shares of Core Scientific worth $6.46M as of Q2 2026.
CastleKnight Management sold 15,700 Core Scientific shares in Q2 2026, an estimated $370K.
Core Scientific made up 0.09% of CastleKnight Management's portfolio in Q2 2026, its #165 holding.
CastleKnight Management first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
CastleKnight Management's Core Scientific position peaked at $13.4M in Q1 2025.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.